TSS
PPBT

Two Sigma Securities’s Purple Biotech PPBT Stock Holding History

Two Sigma Securities’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,537
Closed -$72.1K – 2046
2024
Q4 		$72.1K Buy
+1,537
New +$59.2K 0.01% 1146
2020
Q3 		– Sell
-127
Closed -$281K – 1581
2020
Q2 		$281K Buy
127
+119
+1,488% +$117K 0.01% 939
2020
Q1 		$5K Buy
+8
New +$9.8K ﹤0.01% 1261
2019
Q1 		– Sell
-9
Closed -$12K – 2301
2018
Q4 		$12K Buy
+9
New +$22.6K ﹤0.01% 2000
2018
Q2 		– Sell
-5
Closed -$23K – 2933
2018
Q1 		$23K Buy
+5
New +$25.2K ﹤0.01% 2566

Other funds holding PPBT

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Two Sigma Securities's PPBT Position: Q1 2025 in Review

Two Sigma Securities sold out of Purple Biotech (PPBT) in Q1 2025, closing a stake of 1,537 shares — an estimated $72.1K sold.

Two Sigma Securities first reported a position in PPBT in Q1 2018 and held it in 5 quarters. The position peaked at $281K in Q2 2020. 9 funds tracked by Wall St. Rank hold PPBT as of Q1 2025.

  • Two Sigma Securities reported no remaining Purple Biotech position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,537 Purple Biotech shares in Q1 2025, an estimated $72.1K.
  • Two Sigma Securities first reported a position in Purple Biotech in Q1 2018 and held it in 5 quarters.
  • Two Sigma Securities's Purple Biotech position peaked at $281K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.